Mitochondrial regulatory mechanisms in spinal cord injury: A narrative review
Open Access
- 18 November 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (46) , e31930
Abstract
Spinal cord injury is a severe central nervous system injury that results in the permanent loss of motor, sensory, and autonomic functions below the level of injury with limited recovery. The pathological process of spinal cord injury includes primary and secondary injuries, characterized by a progressive cascade. Secondary injury impairs the ability of the mitochondria to maintain homeostasis and leads to calcium overload, excitotoxicity, and oxidative stress, further exacerbating the injury. The defective mitochondrial function observed in these pathologies accelerates neuronal cell death and inhibits regeneration. Treatment of spinal cord injury by preserving mitochondrial biological function is a promising, although still underexplored, therapeutic strategy. This review aimed to explore mitochondrial-based therapeutic advances after spinal cord injury. Specifically, it briefly describes the characteristics of spinal cord injury. It then broadly discusses the drugs used to protect the mitochondria (e.g., cyclosporine A, acetyl-L-carnitine, and alpha-tocopherol), phenomena associated with mitochondrial damage processes (e.g., mitophagy, ferroptosis, and cuproptosis), mitochondrial transplantation for nerve cell regeneration, and innovative mitochondrial combined protection therapy.Keywords
This publication has 127 references indexed in Scilit:
- Functional Recovery of Human Cells Harbouring the Mitochondrial DNA Mutation MERRF A8344G via Peptide-Mediated Mitochondrial DeliveryNeurosignals, 2012
- Acetyl-l-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recoveryNeuroscience, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Optic atrophy plus phenotype due to mutations in the OPA1 gene: Two more Italian familiesJournal of the Neurological Sciences, 2011
- Post-Injury Administration of the Mitochondrial Permeability Transition Pore Inhibitor, NIM811, Is Neuroprotective and Improves Cognition after Traumatic Brain Injury in RatsJournal of Neurotrauma, 2011
- Is mPTP the gatekeeper for necrosis, apoptosis, or both?Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Targeting Mitochondrial Function for the Treatment of Acute Spinal Cord InjuryNeurotherapeutics, 2011
- Calcium‐dependent mitochondrial function and dysfunction in neuronsThe FEBS Journal, 2010
- Lipid Peroxidation-Derived Reactive Aldehydes Directly and Differentially Impair Spinal Cord and Brain Mitochondrial FunctionJournal of Neurotrauma, 2010
- PINK1-dependent recruitment of Parkin to mitochondria in mitophagyProceedings of the National Academy of Sciences, 2009